Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceutic...

FDA Drug Recall #D-0027-2022 — Class II — October 8, 2021

Recall Summary

Recall Number D-0027-2022
Classification Class II — Moderate risk
Date Initiated October 8, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Lupin Pharmaceuticals Inc.
Location Baltimore, MD
Product Type Drugs
Quantity 1,902 bottles

Product Description

Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06

Reason for Recall

Out of specification result observed in a dissolution test at the 9-month long term stability time point.

Distribution Pattern

Distributed Nationwide in the USA.

Lot / Code Information

lot H002205, exp. date 08/2023

Other Recalls from Lupin Pharmaceuticals Inc.

Recall # Classification Product Date
D-0220-2026 Class II Ganirelix Acetate Injection, 250 mcg/0.5mL, Sin... Nov 13, 2025
D-0227-2026 Class II Sertraline Hydrochloride Tablets USP, 100 mg, 9... Nov 5, 2025
D-0542-2025 Class II Amlodipine and Benazepril HCl Capsules USP 2.5 ... Jul 2, 2025
D-0537-2025 Class II clomiPRAMINE Hydrochloride Capsules USP 25 mg, ... Jun 27, 2025
D-0532-2025 Class II Lisinopril and Hydrochlorothiazide Tablets USP ... Jun 20, 2025

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.